Targeting the TME presents several challenges: 1. Heterogeneity: The composition of the TME can vary significantly between patients and even within different regions of the same tumor. 2. Dynamic Nature: The TME is constantly evolving, making it difficult to target static components. 3. Side Effects: Modulating the TME can affect normal tissues and lead to unintended side effects.
